Threat to Clinical Pathology Laboratories is Payer Pre-Authorization of Genetic Tests

Apr 8, 2011 | Laboratory News, Laboratory Pathology

Health insurers want to control the rapid growth in expensive genetic and molecular assays For many clinical laboratories and pathology groups, genetic tests and molecular diagnostic assays are the fastest-growing part of the test menu. This is true both in the increased volume of specimens for genetic tests and the growing number of such medical laboratory tests that are accepted for clinical use. This is a bright spot for the nation’s clinical pathology laboratories. That’s because many...
;